{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:41:40Z","timestamp":1793410900828,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81622018"],"award-info":[{"award-number":["81622018"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072096"],"award-info":[{"award-number":["82072096"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82401766"],"award-info":[{"award-number":["82401766"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Research Personnel Cultivation Programme of Zhongda Hospital Southeast University","award":["CZXM-GSP-RC40"],"award-info":[{"award-number":["CZXM-GSP-RC40"]}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["SBK2024044439"],"award-info":[{"award-number":["SBK2024044439"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00406-025-01965-6","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T06:14:24Z","timestamp":1739945664000},"page":"619-627","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Atypical antipsychotic drugs cause abnormal glucose and lipid metabolism independent of weight gain"],"prefix":"10.1007","volume":"275","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1224-5315","authenticated-orcid":false,"given":"Ye","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1758-4738","authenticated-orcid":false,"given":"Renrong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"key":"1965_CR1","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/s0140-6736(19)31135-3","volume":"394","author":"M Huhn","year":"2019","unstructured":"Huhn M, Schneider-Thoma NA, Krause J, Samara M, Peter M, Arndt N, B\u00e4ckers T, Rothe L, Cipriani P, Davis A, Salanti J, Leucht G S (2019) Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet 394:939\u2013951. https:\/\/doi.org\/10.1016\/s0140-6736(19)31135-3","journal-title":"Lancet"},{"key":"1965_CR2","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/s0140-6736(13)60733-3","volume":"382","author":"S Leucht","year":"2013","unstructured":"Leucht S, Cipriani A, Spineli L, Mavridis D, \u00d6rey D, Richter F, Samara M, Barbui C, Engel RR, Geddes JR, Kissling W, Stapf MP, L\u00e4ssig B, Salanti G, Davis JM (2013) Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet 382:951\u2013962. https:\/\/doi.org\/10.1016\/s0140-6736(13)60733-3","journal-title":"Lancet"},{"issue":"10","key":"1965_CR3","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.3390\/ijms18102174","volume":"18","author":"SW Jeon","year":"2017","unstructured":"Jeon SW, Kim YK (2017) Unresolved issues for utilization of atypical antipsychotics in Schizophrenia: antipsychotic polypharmacy and metabolic syndrome. Int J Mol Sci 18(10):2174. https:\/\/doi.org\/10.3390\/ijms18102174","journal-title":"Int J Mol Sci"},{"key":"1965_CR4","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41569-020-00463-7","volume":"18","author":"RE Nielsen","year":"2020","unstructured":"Nielsen RE, Banner J, Jensen SE (2020) Cardiovascular disease in patients with severe mental illness. Nat Reviews Cardiol 18:136\u2013145. https:\/\/doi.org\/10.1038\/s41569-020-00463-7","journal-title":"Nat Reviews Cardiol"},{"key":"1965_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/schbul\/sbq042","volume":"38","author":"C Rummel-Kluge","year":"2012","unstructured":"Rummel-Kluge C, Komossa K, Schwarz S, Hunger H, Schmid F, Kissling W, Davis JM, Leucht S (2012) Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons. Schizophr Bull 38:167\u2013177. https:\/\/doi.org\/10.1093\/schbul\/sbq042","journal-title":"Schizophr Bull"},{"issue":"Suppl 3","key":"1965_CR6","doi-asserted-by":"publisher","first-page":"S149","DOI":"10.1016\/j.euroneuro.2006.06.003","volume":"16","author":"DW Haupt","year":"2006","unstructured":"Haupt DW (2006) Differential metabolic effects of antipsychotic treatments. Eur Neuropsychopharmacol 16(Suppl 3):S149\u2013S155. https:\/\/doi.org\/10.1016\/j.euroneuro.2006.06.003","journal-title":"Eur Neuropsychopharmacol"},{"key":"1965_CR7","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/mp.2010.33","volume":"16","author":"VL Albaugh","year":"2010","unstructured":"Albaugh VL, Judson JG, She P, Lang CH, Maresca KP, Joyal JL, Lynch CJ (2010) Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis. Mol Psychiatry 16:569\u2013581. https:\/\/doi.org\/10.1038\/mp.2010.33","journal-title":"Mol Psychiatry"},{"key":"1965_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/1359786806071243","volume":"20","author":"MS Turner","year":"2006","unstructured":"Turner MS, Stewart DW (2006) Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses. J Psychopharmacol 20:20\u201337. https:\/\/doi.org\/10.1177\/1359786806071243","journal-title":"J Psychopharmacol"},{"issue":"1","key":"1965_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1001\/archpsyc.62.1.19","volume":"62","author":"DC Henderson","year":"2006","unstructured":"Henderson DC, Cagliero E, Copeland PM, Borba CP, Evins AE, Hayden D, Weber MT, Anderson EJ, Allison DB, Daley, TB (2006) Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis. Arch Gen Psychiatry 62(1):19\u201328. https:\/\/doi.org\/10.1001\/archpsyc.62.1.19","journal-title":"Arch Gen Psychiatry"},{"key":"1965_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1001\/archpsyc.59.4.337","volume":"59","author":"JW Newcomer","year":"2002","unstructured":"Newcomer JW, Haupt DW, Fucetola R, Melson AK, Schweiger JA, Cooper BP, Selke G (2002) Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia. Arch Gen Psychiatry 59:337\u2013345. https:\/\/doi.org\/10.1001\/archpsyc.59.4.337","journal-title":"Arch Gen Psychiatry"},{"key":"1965_CR11","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/JCP.0b013e318166c4f7","volume":"28","author":"AB Birkenaes","year":"2008","unstructured":"Birkenaes AB, Birkeland KI, Engh JA, Faerden A, Jonsdottir H, Ringen PA, Friis S, Opjordsmoen S, Andreassen OA (2008) Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions. J Clin Psychopharmacol 28:132\u2013137. https:\/\/doi.org\/10.1097\/JCP.0b013e318166c4f7","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"1965_CR12","doi-asserted-by":"publisher","first-page":"242","DOI":"10.4306\/pi.2015.12.2.242","volume":"12","author":"SH Kang","year":"2015","unstructured":"Kang SH, Lee JI (2015) Metabolic disturbances independent of body mass in patients with schizophrenia taking atypical antipsychotics. Psychiatry Investig 12(2):242\u2013248. https:\/\/doi.org\/10.4306\/pi.2015.12.2.242Epub 2015 Mar 18","journal-title":"Psychiatry Investig"},{"key":"1965_CR13","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/01.paf.0000127391.85007.f4","volume":"25","author":"J Avella","year":"2004","unstructured":"Avella J, Wetli CV, Wilson JC, Katz M, Hahn T (2004) Fatal olanzapine-induced hyperglycemic ketoacidosis. Am J Forensic Med Pathol 25:172\u2013175. https:\/\/doi.org\/10.1097\/01.paf.0000127391.85007.f4","journal-title":"Am J Forensic Med Pathol"},{"key":"1965_CR14","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/JCP.0b013e318184b4c5","volume":"28","author":"AF Chintoh","year":"2008","unstructured":"Chintoh AF, Mann SW, Lam L, Lam C, Cohn TA, Fletcher PJ, Nobrega JN, Giacca A, Remington G (2008) Insulin resistance and decreased glucose-stimulated insulin secretion after acute olanzapine administration. J Clin Psychopharmacol 28:494\u2013499. https:\/\/doi.org\/10.1097\/JCP.0b013e318184b4c5","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"1965_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00213-013-3193-7","volume":"229","author":"H Yan","year":"2013","unstructured":"Yan H, Chen JD, Zheng XY (2013) Potential mechanisms of atypical antipsychotic-induced hypertriglyceridemia. Psychopharmacology 229(1):1\u20137. https:\/\/doi.org\/10.1007\/s00213-013-3193-7Epub 2013 Jul 6","journal-title":"Psychopharmacology"},{"issue":"5","key":"1965_CR16","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00210-010-0499-4","volume":"381","author":"E Lauressergues","year":"2010","unstructured":"Lauressergues E, Staels B, Valeille K, Majd Z, Hum DW, Duriez P, Cussac D (2010) Antipsychotic drug action on SREBPs-related lipogenesis and cholesterogenesis in primary rat hepatocytes. Naunyn Schmiedebergs Arch Pharmacol 381(5):427\u2013439. https:\/\/doi.org\/10.1007\/s00210-010-0499-4Epub 2010 Mar 24","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"5","key":"1965_CR17","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/sj.tpj.6500323","volume":"5","author":"J Ferno","year":"2005","unstructured":"Ferno J, Raeder MB, Vik-Mo AO, Skrede S, Glambek M, Tronstad KJ, Breilid H, Lovlie R, Berge RK, Stansberg (2005) Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: a novel mechanism of action? Pharmacogenomics J 5(5):298\u2013304. https:\/\/doi.org\/10.1038\/sj.tpj.6500323","journal-title":"Pharmacogenomics J"},{"issue":"1","key":"1965_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12888-020-03034-9","volume":"21","author":"J Lu","year":"2021","unstructured":"Lu J, Yang Y, Lu J, Wang Z, He Y, Yan Y, Fu K, Jiang W, Xu Y, Wu R, Liu W, Zhao J (2021) Effect of CYP2D6 polymorphisms on plasma concentration and therapeutic effect of risperidone. BMC Psychiatry 21(1):70. https:\/\/doi.org\/10.1186\/s12888-020-03034-9","journal-title":"BMC Psychiatry"},{"issue":"7","key":"1965_CR19","doi-asserted-by":"publisher","first-page":"e28832","DOI":"10.1016\/j.heliyon.2024.e28832","volume":"10","author":"Y Yang","year":"2024","unstructured":"Yang Y, Liu W, Wu R (2024) Effects of CYP2D6 gene polymorphism on plasma concentration and therapeutic effect of olanzapine. Heliyon 10(7):e28832. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28832eCollection 2024 Apr 15","journal-title":"Heliyon"},{"issue":"2","key":"1965_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1017\/S1461145711001271","volume":"15","author":"S Skrede","year":"2012","unstructured":"Skrede S, Ferno J, Vazquez MJ, Fjaer S, Pavlin T, Lunder N, Vidal-Puig A, Dieguez C, Berge RK, Lopez M (2012) Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats. Int J Neuropsychopharmacol 15(2):163\u2013179","journal-title":"Int J Neuropsychopharmacol"},{"issue":"4","key":"1965_CR21","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.orcp.2015.08.012","volume":"10","author":"D Arterburn","year":"2016","unstructured":"Arterburn D, Wood GC, Theis MK, Westbrook EO, Anau J, Rukstalis M, Boscarino JA, Daar Z, Gerhard GS (2016) Antipsychotic medications and extreme weight gain in two health systems. Obes Res Clin Pract 10(4):408\u2013423 Epub 2015 Sep 8","journal-title":"Obes Res Clin Pract"},{"key":"1965_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00213-021-06042-z","volume":"239","author":"J Huang","year":"2022","unstructured":"Huang J, Xiao J, Peng Z, Shao P, Sun M, Long Y, Wang X, Shen M, Kang D, Yang Y, Peng X, Wang W, Xie P, Shao T, Zhao J, Wu R (2022) PCSK9 mediates dyslipidemia induced by olanzapine treatment in schizophrenia patients. Psychopharmacology 239:83\u201391. https:\/\/doi.org\/10.1007\/s00213-021-06042-z","journal-title":"Psychopharmacology"},{"issue":"6","key":"1965_CR23","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1176\/appi.ajp.159.6.1058","volume":"159","author":"M Poyurovsky","year":"2002","unstructured":"Poyurovsky M, Pashinian A, Gil-Ad I, Maayan R, Schneidman M, Fuchs C, Weizman A (2002) Olanzapine-induced weight gain in patients with first-episode schizophrenia: a double-blind, placebo-controlled study of fluoxetine addition. Am J Psychiatry 159(6):1058\u20131060. https:\/\/doi.org\/10.1176\/appi.ajp.159.6.1058","journal-title":"Am J Psychiatry"},{"key":"1965_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cdtm.2016.11.001","volume":"3","author":"DY Hu","year":"2017","unstructured":"Hu DY (2017) New guidelines and evidence for prevention and treatment of dyslipidemia and atherosclerotic cardiovascular disease in China\u2606. Chronic Dis Translational Med 3:73\u201374. https:\/\/doi.org\/10.1016\/j.cdtm.2016.11.001","journal-title":"Chronic Dis Translational Med"},{"issue":"2","key":"1965_CR25","doi-asserted-by":"publisher","first-page":"e00119","DOI":"10.1002\/edm2.119","volume":"3","author":"A Nahmias","year":"2020","unstructured":"Nahmias A, Stahel P, Dash S (2020) Assessment of lipid response to acute olanzapine administration in healthy adults. Endocrinol Diabetes Metabolism 28 3(2):e00119. https:\/\/doi.org\/10.1002\/edm2.119eCollection 2020 Apr","journal-title":"Endocrinol Diabetes Metabolism 28"},{"issue":"3","key":"1965_CR26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2169\/internalmedicine.47.0557","volume":"47","author":"T Nagamine","year":"2008","unstructured":"Nagamine T (2008) Olanzapine-induced elevation of serum triglyceride levels in a normal weight patient with Schizophrenia. Intern Med 47(3):181\u2013182. https:\/\/doi.org\/10.2169\/internalmedicine.47.0557Epub 2008 Feb 1","journal-title":"Intern Med"},{"key":"1965_CR27","doi-asserted-by":"publisher","unstructured":"JM. M.(2001) Novel antipsychotics and severe hyperlipidemia. J Clin Psychopharmacol 21(4):369\u2013374. https:\/\/doi.org\/10.1097\/00004714-200108000-00003","DOI":"10.1097\/00004714-200108000-00003"},{"key":"1965_CR28","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.lfs.2015.01.033","volume":"128","author":"X Liu","year":"2015","unstructured":"Liu X, Deng C, Cao S, Gong J, Wang B-C, Hu C-H (2015) Acute effects of oral olanzapine treatment on the expression of fatty acid and cholesterol metabolism-related gene in rats. Life Sci 128:72\u201378. https:\/\/doi.org\/10.1016\/j.lfs.2015.01.033","journal-title":"Life Sci"},{"issue":"6","key":"1965_CR29","doi-asserted-by":"publisher","first-page":"E1101","DOI":"10.1152\/ajpendo.00309.2020","volume":"319","author":"KD Medak","year":"2020","unstructured":"Medak KD, Shamshoum H, Peppler WT, Wright DC (2020) GLP1 receptor agonism protects against acute olanzapine-induced hyperglycemia. Am J Physiol Endocrinol Metab 319(6):E1101\u2013E1111. https:\/\/doi.org\/10.1152\/ajpendo.00309.2020Epub 2020 Oct 5","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1965_CR30","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1097\/JCP.0b013e31829e8333","volume":"33","author":"MK Hahn","year":"2013","unstructured":"Hahn MK, Wolever TM, Arenovich T, Teo C, Giacca A, Powell V, Clarke L, Fletcher P, Cohn T, McIntyre RS, Gomes S, Chintoh A, Remington GJ (2013) Acute effects of single-dose olanzapine on metabolic, endocrine, and inflammatory markers in healthy controls. J Clin Psychopharmacol 33:740\u2013746. https:\/\/doi.org\/10.1097\/JCP.0b013e31829e8333","journal-title":"J Clin Psychopharmacol"},{"key":"1965_CR31","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.2337\/db13-0430","volume":"62","author":"KL Teff","year":"2013","unstructured":"Teff KL, Rickels MR, Grudziak J, Fuller C, Nguyen H-L, Rickels K (2013) Antipsychotic-Induced insulin resistance and Postprandial Hormonal Dysregulation Independent of Weight Gain or Psychiatric Disease. Diabetes 62:3232\u20133240. https:\/\/doi.org\/10.2337\/db13-0430","journal-title":"Diabetes"},{"key":"1965_CR32","doi-asserted-by":"publisher","first-page":"E250","DOI":"10.1152\/ajpendo.00315.2017","volume":"315","author":"MR Rickels","year":"2018","unstructured":"Rickels MR, Perez EM, Peleckis AJ, Alshehabi E, Nguyen HL, Stefanovski D, Rickels K, Teff KL (2018) Contribution of parasympathetic muscarinic augmentation of insulin secretion to olanzapine-induced hyperinsulinemia. Am J Physiol Endocrinol Metab 315:E250\u2013E257. https:\/\/doi.org\/10.1152\/ajpendo.00315.2017","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1965_CR33","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/dom.12148","volume":"15","author":"M Ikegami","year":"2013","unstructured":"Ikegami M, Ikeda H, Ohashi T, Ohsawa M, Ishikawa Y, Kai M, Kamei A, Kamei J (2013) Olanzapine increases hepatic glucose production through the activation of hypothalamic adenosine 5\u2019-monophosphate-activated protein kinase. Diabetes Obes Metab 15:1128\u20131135. https:\/\/doi.org\/10.1111\/dom.12148","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"1965_CR34","doi-asserted-by":"publisher","first-page":"425","DOI":"10.4088\/jcp.v63n0509","volume":"63","author":"JM Meyer","year":"2002","unstructured":"Meyer JM (2002) A retrospective comparison of weight, lipid, and glucose changes between risperidone- and olanzapine-treated inpatients: metabolic outcomes after 1 year. J Clin Psychiatry 63(5):425\u2013433. https:\/\/doi.org\/10.4088\/jcp.v63n0509","journal-title":"J Clin Psychiatry"},{"issue":"10","key":"1965_CR35","doi-asserted-by":"publisher","first-page":"856","DOI":"10.4088\/jcp.v63n1002","volume":"63","author":"DABJ Wirshing","year":"2002","unstructured":"Wirshing DABJ, Meng LR, Ballon JS, Marder SR, Wirshing WC (2002) The effects of novel antipsychotics on glucose and lipid levels. J Clin Psychiatry 63(10):856\u2013865. https:\/\/doi.org\/10.4088\/jcp.v63n1002","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"1965_CR36","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.4088\/jcp.v67n0922e","volume":"67","author":"JdL Courtney Markham-Abedi","year":"2006","unstructured":"Courtney Markham-Abedi JdL (2006) Hypertriglyceridemia associated with direct effects of olanzapine rather than with weight gain: a case report. J Clin Psychiatry 67(9):1473\u20131474. https:\/\/doi.org\/10.4088\/jcp.v67n0922e","journal-title":"J Clin Psychiatry"},{"key":"1965_CR37","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.jpsychires.2009.01.010","volume":"43","author":"GM Reaven","year":"2009","unstructured":"Reaven GM, Lieberman JA, Sethuraman G, Kraemer H, Davis JM, Blasey C, Tsuang MT, Schatzberg AF (2009) In search of moderators and mediators of hyperglycemia with atypical antipsychotic treatment. J Psychiatr Res 43:997\u20131002. https:\/\/doi.org\/10.1016\/j.jpsychires.2009.01.010","journal-title":"J Psychiatr Res"},{"issue":"10","key":"1965_CR38","doi-asserted-by":"publisher","first-page":"e661","DOI":"10.1038\/tp.2015.161","volume":"5","author":"HL Cai","year":"2015","unstructured":"Cai HL, Tan QY, Jiang P, Dang RL, Xue Y, Tang MM, Xu P, Deng Y, Li HD, Yao JK (2015).A potential mechanism underlying atypical antipsychotics-induced lipid disturbances. Transl Psychiatry 5(10):e661. https:\/\/doi.org\/10.1038\/tp.2015.161","journal-title":"Transl Psychiatry"},{"issue":"1","key":"1965_CR39","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/s0920-9964(02)00498-x","volume":"66","author":"PJ Weiden","year":"2004","unstructured":"Weiden PJ, Mackell JA, McDonnell DD (2004) Obesity as a risk factor for antipsychotic noncompliance. Schizophr Res 66(1):51\u201357. https:\/\/doi.org\/10.1016\/s0920-9964(02)00498-x","journal-title":"Schizophr Res"},{"key":"1965_CR40","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.eurpsy.2017.02.487","volume":"43","author":"N Jayatilleke","year":"2017","unstructured":"Jayatilleke N, Hayes RD, Dutta R, Shetty H, Hotopf M, Chang CK, Stewart R (2017) Contributions of specific causes of death to lost life expectancy in severe mental illness. Eur Psychiatry 43:109\u2013115. https:\/\/doi.org\/10.1016\/j.eurpsy.2017.02.487","journal-title":"Eur Psychiatry"},{"key":"1965_CR41","doi-asserted-by":"publisher","unstructured":"Melkersson KI, Dahl ML, Hulting AL (2004) Guidelines for prevention and treatment of adverse effects of antipsychotic drugs on glucose?insulin homeostasis and lipid metabolism. Psychopharmacology175(1):1\u20136. https:\/\/doi.org\/10.1007\/s00213-004-1922-7. Epub 2004 Jun 25","DOI":"10.1007\/s00213-004-1922-7"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-025-01965-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00406-025-01965-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-025-01965-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T12:15:43Z","timestamp":1749039343000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00406-025-01965-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["1965"],"URL":"https:\/\/doi.org\/10.1007\/s00406-025-01965-6","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,19]]},"assertion":[{"value":"27 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised due to the updated funding note in the article.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original article has been corrected.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Human Ethics Committee of the Second Xiangya Hospital of Central South University and the Third People\u2019s Hospital of Jiangyin City.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Patients signed informed consent regarding publishing their anonymized data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}